| Code | Description | Claims | Beneficiaries | Total Paid |
| H1000 |
Prenatal care, at-risk assessment |
6,425 |
4,341 |
$274K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
2,249 |
1,886 |
$87K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
1,062 |
947 |
$75K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,259 |
2,090 |
$47K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
668 |
651 |
$38K |
| 59430 |
|
666 |
569 |
$24K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
367 |
352 |
$23K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
838 |
778 |
$14K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
361 |
208 |
$10K |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
1,321 |
1,270 |
$9K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
160 |
152 |
$6K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
100 |
100 |
$6K |
| 36415 |
Collection of venous blood by venipuncture |
3,259 |
2,910 |
$5K |
| 59025 |
Fetal non-stress test |
340 |
232 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
548 |
515 |
$4K |
| H1001 |
Prenatal care, at-risk enhanced service; antepartum management |
32 |
31 |
$3K |
| 81025 |
|
1,599 |
1,503 |
$3K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
241 |
135 |
$3K |
| 3074F |
|
8,142 |
6,259 |
$604.23 |
| 86850 |
|
257 |
236 |
$553.84 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
48 |
15 |
$489.44 |
| 81003 |
|
580 |
474 |
$487.77 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
144 |
103 |
$485.00 |
| 90715 |
|
33 |
29 |
$454.83 |
| 85018 |
|
630 |
581 |
$373.55 |
| 0503F |
|
1,059 |
745 |
$355.57 |
| 0502F |
|
5,986 |
3,832 |
$322.04 |
| 3079F |
|
1,541 |
1,265 |
$206.12 |
| 0501F |
|
592 |
482 |
$152.76 |
| 96160 |
|
620 |
499 |
$149.56 |
| G0124 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician |
191 |
132 |
$51.39 |
| 99000 |
|
3,479 |
2,824 |
$48.00 |
| 0500F |
|
573 |
506 |
$25.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
39 |
35 |
$12.27 |
| 3075F |
|
666 |
587 |
$0.01 |
| 1159F |
|
2,565 |
2,121 |
$0.01 |
| 1160F |
|
1,728 |
1,431 |
$0.01 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
375 |
289 |
$0.00 |
| 1036F |
|
985 |
833 |
$0.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
16 |
16 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
243 |
202 |
$0.00 |
| 3008F |
|
379 |
336 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
14 |
14 |
$0.00 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
16 |
14 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
12 |
12 |
$0.00 |
| 36416 |
|
33 |
29 |
$0.00 |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
55 |
48 |
$0.00 |
| 1034F |
|
16 |
13 |
$0.00 |
| 86592 |
|
15 |
15 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
3,058 |
2,100 |
$0.00 |
| 3078F |
|
7,672 |
5,593 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
692 |
548 |
$0.00 |
| 3077F |
|
26 |
24 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
27 |
27 |
$0.00 |
| 90832 |
Psychotherapy, 30 minutes with patient |
47 |
35 |
$0.00 |
| 81002 |
|
60 |
58 |
$0.00 |